ALEJANDRO
MOLINA LEYVA
DOCENTE INVITADO
![Foto de ALEJANDRO](/img/nophoto.png)
![Foto de Corporació Sanitària Parc Taulí](/img/noimage_org.png)
Corporació Sanitària Parc Taulí
Barcelona, EspañaPublications en collaboration avec des chercheurs de Corporació Sanitària Parc Taulí (3)
2023
-
Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”
Journal of the American Academy of Dermatology
2021
-
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study
Journal of the American Academy of Dermatology, Vol. 85, Núm. 2, pp. 369-378
2019
-
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes
Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1455-1457